RMGP Biopharma Investment Fund
Venture capitalHerzliya · Seed–Series A · 6 people tracked
Find your way into RMGP Biopharma Investment Fund
Sign up to see every warm intro you have to RMGP Biopharma Investment Fund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RMGP Biopharma Investment Fund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
RMGP Biopharma Investment Fund invests in early-stage therapeutic companies, partnering with OrbiMed, Johnson & Johnson, and Takeda through the FutuRx incubator. The fund is managed by RM Global Healthcare Fund Management.
Team · 6 people
from public directoriesInvestments · 1 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ImmPACT Bio USA Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does RMGP Biopharma Investment Fund invest at?
- RMGP Biopharma Investment Fund invests at the Seed, Series A stages.
- What sectors does RMGP Biopharma Investment Fund focus on?
- RMGP Biopharma Investment Fund focuses on Biotech.
- Where is RMGP Biopharma Investment Fund located?
- RMGP Biopharma Investment Fund is headquartered in Herzliya, IL.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.



.jpeg)